Gossypium herbaceam extracts inhibited NF-κB activation to attenuate spatial memory impairment and hippocampal neurodegeneration induced by amyloid-β in rats

Journal of Alzheimer's Disease

Volumn 14, Issue 3, 2008, Pages 271-283

  Ji, Chao ^c   Aisa, Haji Akber ^d   Yang, Nan ^c   Li, Qing ^c   Wang, Tao ^c   Zhang, Ling ^b   Qu, Kai ^b   Zhu, Hai Bo ^b   Zuo, Ping Ping ^a,c  

^a Department of Pharmacology   (China)

^b INSTITUTE OF MATERIA MEDICA   (China)

^c INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^d XINJIANG TECHNICAL INSTITUTE OF PHYSICS AND CHEMISTRY   (China)

Author keywords

Alzheimer's disease; Amyloid ; Antioxidant stress; Apoptosis; Gossypium herbaceam; NF B

Indexed keywords

AMYLOID BETA PROTEIN[25-35]; ANTIOXIDANT; CATALASE; DONEPEZIL; GLUTATHIONE PEROXIDASE; GOSSYPIUM HERBACEAM EXTRACT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PLANT EXTRACT;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; GOSSYPIUM HERBACEAM; HIPPOCAMPUS; HISTOCHEMISTRY; IN VIVO STUDY; LEARNING DISORDER; MALE; MAZE TEST; MEDICINAL PLANT; MEMORY DISORDER; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 47849133237     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2008-14302     Document Type: Article

References (26)

1. A.Y. Abramov, L. Canevari and M.R. Duchen, Changes in intracellular calcium and glutathione in astrocytes as the primary mechanism of amyloid neurotoxicity, J Neurosci 23 (2003), 5088-5095.
2. H. Akiyama, S. Barger, S. Barnum, B. Bradt, J. Bauer, G.M. Cole, N.R. Cooper, P. Eikelenboom, M. Emmerling, B.L. Fiebich, C.E. Finch, S. Frautschy, W.S. Griffin, H. Hampel, M. Hull, G. Landreth, L. Lue, R. Mrak, I.R. Mackenzie, P.L. McGeer, M.K. O'Banion, J. Pachter, G. Pasinetti, C. Plata-Salaman, J. Rogers, R. Rydel, Y. Shen, W. Streit, R. Strohmeyer, I. Tooyoma, F.L. Van Muiswinkel, R. Veerhuis, D. Walker, S. Webster, B. Wegrzyniak, G. Wenk and T. Wyss-Coray, Inflammation and Alzheimer's disease, Neurobiol Aging 21 (2000), 383-421.
3. T.S. Anekonda and P.H. Reddy, Can herbs provide a new generation of drugs for treating Alzheimer's disease, Brain Res Brain Res Rev 50 (2005), 361-376.
4. R.T. Bartus, R.L. Dean, S. Mennerick, D. Eveleth and G. Lynch, Temporal ordering of pathogenic events following transient global ischemia, Brain Res 790 (1998), 1-13.
5. D. Chen, C.F. Wu, B. Shi and Y.M. Xu, Tamoxifen and toremifene cause impairment of learning and memory function in mice, Pharmacol Biochem Behav 71 (2002), 269-276.
6. C. Culmsee, J. Siewe, V. Junker, M. Retiounskaia, S. Schwarz, S. Camandola, S. El-Metainy, H. Behnke, M.P. Mattson and J. Krieglstein, Reciprocal inhibition of p53 and nuclear factor-kappaB transcriptional activities determines cell survival or death in neurons, J Neurosci 23 (2003), 8586-8595.
7. S. Delobette, A. Privat and T. Maurice, In vitro aggregation facilities beta-amyloid peptide-(25-35)-induced amnesia in the rat, Eur J Pharmacol 319 (1997), 1-4.
8. P. Eikelenboom and W.A. van Gool, Neuroinflammatory perspectives on the two faces of Alzheimer's disease, J Neural Transm 111 (2004), 281-294.
9. G. Esposito, D. De Filippis, R. Carnuccio, A.A. Izzo and T. Iuvone, The marijuana component cannabidiol inhibits beta-amyloid-induced tau protein hyperphosphorylation through Wnt/beta-catenin pathway rescue in PC12 cells, J Mol Med 84 (2006), 253-258.
10. I. Ferrer, E. Marti, E. Lopez and A. Tortosa, NF-kB immunoreactivity is observed in association with beta A4 diffuse plaques in patients with Alzheimer's disease, Neuropathol Appl Neurobiol 24 (1998), 271-277.
11. P. Geng, R. Zhang, H.A. Aisa, J. He, K. Qu, H. Zhu and Z. Abliz, Fast profiling of the integral metabolism of flavonols in the active fraction of Gossypium herbaceam L. using liquid chromatography/multi-stage tandem mass spectrometry, Rapid Commun Mass Spectrom 21 (2007), 1877-1888.
12. J.A. Hardy and G.A. Higgins, Alzheimer's disease: the amyloid cascade hypothesis, Science 256 (1992), 184-185.
13. X. Huang, C.S. Atwood, M.A Hartshorn, G. Multhaup, L.E. Goldstein, R.C. Scarpa, M.P. Cuajungco, D.N. Gray, J. Lim, R.D. Moir, R.E. Tanzi and A.I. Bush, The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. Biochemistry 38 (1999), 7609-7616.
14. S.Y. Lee, J.W. Lee, H. Lee, H.S. Yoo, Y.P. Yun, K.W. Oh, T.Y. Ha and J.T. Hong, Inhibitory effect of green tea extract on beta-amyloid-induced PC12 cell death by inhibition of the activation of NF-kappaB and ERK/p38 MAP kinase pathway through antioxidant mechanisms, Brain Res Mol Brain Res 140 (2005), 45-54.
15. F. Longpre, P. Garneau, Y. Christen and C. Ramassamy, Protection by EGb 761 against beta-amyloid-induced neurotoxicity: involvement of NF-kappaB, SIRT1, and MAPKs pathways and inhibition of amyloid fibril formation, Free Radic Biol Med 41 (2006), 1781-1794.
16. T. Maurice, B.P. Lockhart and A. Privat, Amnesia induced in mice by centrally administered beta-amyloid peptides involves cholinergic dysfunction, Brain Res 706 (1996), 181-193.
17. S. Moncada, D.D. Rees, R. Schulz and R.M. Palmer, Development and mechanism of a specific supersensitivity to nitrovasodilators after inhibition of vascular nitric oxide synthesis in vivo, Proc Natl Acad Sci USA 88 (1991), 2166-2170.
18. A. Monji, H. Utsumi, T. Ueda, T. Imoto, I. Yoshida, S. Hashioka, K. Tashiro and N. Tashiro, Amyloid-beta-protein (Abeta) (25-35)-associated free radical generation is strongly influenced by the aggregational state of the peptides, Life Sci 70 (2002), 833-841.
19. R. Morris, Developments of awater-maze procedure for studying spatial learning in the rat, J Neurosci Methods 11 (1984), 47-60.
20. Y. Pan, X. Xu, X. Tong and X. Wang, Messenger RNA and protein expression analysis of voltage-gated potassium channels in the brain of Abeta(25-35)-treated rats, J Neurosci Res 77 (2004), 94-99.
21. B. Puig, T. Gomez-Isla, E. Ribe, M. Cuadrado, B. Torrejon-Escribano, E. Dalfo and I. Ferrer, Expression of stress-activated kinases c-Jun N-terminal kinase (SAPK/JNK-P) and p38 kinase (p38-P), and tau hyperphosphorylation in neurites surrounding betaA plaques in APP Tg2576 mice, Neuropathol Appl Neurobiol 30 (2004), 491-502.
22. M.N. Scholzke, I. Potrovita, S. Subramaniam, S. Prinz and M. Schwaninger, Glutamate activates NF-kappaB through calpain in neurons, Eur J Neurosci 18 (2003), 3305-3310.
23. D.J. Selkoe, Translating cell biology into therapeutic advances in Alzheimer's disease, Nature 399 (1999), A23-A31.
24. K. Terai, A. Matsuo, E.G. McGeer and P.L. McGeer, Enhancement of immunoreactivity for NF-kappa B in human cerebral infarctions, Brain Res 739 (1996), 343-349.
25. F. Torreilles, S. Salman-Tabcheh, M. Guerin and J. Torreilles, Neurodegenerative disorders: the role of peroxynitrite, Brain Res Brain Res Rev 30 (1999), 153-163.
26. Y. Zhou, Y. Su, B. Li, F. Liu, J.W. Ryder, X. Wu, P.A. Gonzalez-DeWhitt, V. Gelfanova, J.E. Hale, P.C. May, S.M. Paul and B. Ni, Nonsteroidal anti-inflammatory drugs can lower amyloidogenic Abeta42 by inhibiting Rho, Science 302 (2003), 1215-1217.